1. Home
  2. List
Reference Patent

Reference - List

  • 9 Hits
  • Search Condition : Filter (MeSH = Bile Duct Neoplasms* / pathology)
Species Resource Title
Human and Animal Cells HuCCT1(RCB1960) Revolutionizing drug delivery: low-intensity pulsed ultrasound (LIPUS)-driven deep penetration into hypoxic tumor microenvironments of cholangiocarcinoma.
Human and Animal Cells TFK-1(RCB2537) SRPK Inhibitors Reduce the Phosphorylation and Translocation of SR Protein Splicing Factors, thereby Correcting BIN1, MCL-1 and BCL2 Splicing Errors and Enabling Apoptosis of Cholangiocarcinoma Cells.
Human and Animal Cells HuCCT1(RCB1960) FGFR inhibition blocks NF-ĸB-dependent glucose metabolism and confers metabolic vulnerabilities in cholangiocarcinoma.
Human and Animal Cells TFK-1(RCB2537) , G-415(RCB2640) Inhibition of dopamine receptor D1 signaling promotes human bile duct cancer progression via WNT signaling.
Human and Animal Cells HuH-7(RCB1366) Ferroptosis-related gene glutathione peroxidase 4 promotes reprogramming of glucose metabolism via Akt-mTOR axis in intrahepatic cholangiocarcinoma.
Human and Animal Cells SSP-25(RCB1293) Mucin 4 Confers Gemcitabine Resistance and an Unfavorable Prognosis in Patients with Cholangiocarcinoma via AKT Activation.
Human and Animal Cells HuCCT1(RCB1960) Elevated ITGA2 expression promotes collagen type I-induced clonogenic growth of intrahepatic cholangiocarcinoma.
DNA material pCMV-VSV-G-RSV-Rev (RDB04393) , pCAG-HIVgp (RDB04394) Concurrent Activation of Kras and Canonical Wnt Signaling Induces Premalignant Lesions That Progress to Extrahepatic Biliary Cancer in Mice.
Human and Animal Cells HuCCT1(RCB1960) CXCR2 signaling might have a tumor-suppressive role in patients with cholangiocarcinoma.